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Abstract 
Proteins are essential for life and as such have been deemed useful as therapeutic agents. However, the 
complexities that make proteins important for biological processes can also make their behaviour 
complicated. Such behaviour can make production, processing and formulation of protein 
pharmaceuticals problematic. A therapeutic protein test system has been examined using infrared 
spectroscopy and differential scanning calorimetry to increase understanding of its behaviour. It has 
been show that the protein thermally denatures at 47 °C and that this is accompanied by changes to the 
structure. 
 
Introduction 
Proteins are long unbranched chain molecules that can adopt complicated three-dimensional structures. 
Their structure is crucial for their biological activity and functionality. However, this structure can 
change under different environmental conditions; the structure can breakdown (denaturation) or be 
subtly altered to regulate biological activity (allosteric effect) or higher order structures can be formed 
(e.g. dimers and aggregates). Understanding this behaviour is required for precise control over protein 
structure and will allow improved processing of biotech products. Also, any understanding gained in 
vitro, motivated by the biotech impetus, would have the additional spin off of a better understanding of 
in vivo processes, with corresponding implications for health. 
A great deal of work has been done on determining the structure of proteins. Separate work has 
involved examining physical behaviour that results from changes in structure. But how can we re-
examine these in order to increase our understanding and answer questions such as: 
How and why do environmental conditions affect subtleties of structure? 
How and why do environmental conditions and any resulting structural changes affect behaviour? 
 
The area of protein structure and the importance of structure for function is well covered in the 
literature (Alberts et al., 2002, Branden and Tooze, 1991). Proteins are made up of amino acids joined 
together by peptide bonds. They commonly contain more than one hundred amino acids and are 
essential elements of living systems. The complicated three-dimensional structures that proteins adopt 
allow them to have varying functional properties. Some exhibit mechanical properties such as 
elasticity or tensile strength; for example: 
• Keratins: form elastic fibres that confer elasticity to the skin 
• Collagen: forms tough fibrils that give connective tissue tensile strength 
Alternatively, proteins might bind to specific molecules for catalysis, molecular recognition or 
transportation, examples include: 
• Enzymes: bind to other molecules to catalyse reactions 
• Calmodulin: binds to calcium in order to alter activity of other proteins 
Proteins can also build up in to larger assemblies; for example: 
• Viruses: identical proteins pack together to form a spherical shell 
• Amyloid: large well ordered assembly of proteins resulting in fibres 
The sequence of amino acids in the long molecular protein chain is referred to as the primary structure. 
Sections of the protein chain can coil, fold or loop. The nature of these localised arrangements is a 
direct result of the amino acid sequence and is referred to as secondary structure. If the backbone coils 
this is referred to as helix, whereas if it forms pleated sheet this is referred to as β-sheet. The localised 
arrangements or secondary structure elements are well documented in the literature. There are two 
common means of defining protein secondary structure, using either backbone torsion angles 
(Ramachandran and Sasisekharan, 1968) or hydrogen bonding pattern (Kabsch and Sander, 1983). 
The spatial arrangement of all the atoms of a protein subunit is referred to as tertiary structure (IUPAC, 
1970). A subunit refers to a distinct chain component within a protein that may be separated from other 
chain components, whether identical or different, without breaking main chain covalent bonds. The 
inter-subunit contacts and interactions of a protein are referred to as quaternary structure (IUPAC, 
1970). A protein molecule that does not have any subunits that can be separated without the braking of 
covalent bonds possesses no quaternary structure. 
 
The classical and simplistic view of protein behaviour is shown in Figure 1; folded protein unfolds and 
then aggregates. This over simplified picture tells us nothing about the nature of the denaturation, 
aggregation or protein structures and how these are interrelated. There are examples of protein 
behaviour in the literature that allow a more universal approach to be taken. This is proposed and 
neatly summarised in Figure 2; links between behaviour are demonstrated and it also allows trends to 
be identified. This is the first time such a representation has been proposed, to the author’s knowledge. 
Whilst the generalisations may not apply to all systems it is the initiation of a more global model and 
approach. 
 
 N (native) ↔ U (unfolded/denatured) → A (aggregated) 
 
Figure 1 Simplistic view of protein behaviour 
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Figure 2 The interrelation and diversity of protein behaviour 
 
The behaviour of proteins is made complicated by their complex three dimensional structures. A 
comprehensive review of protein behaviour exists (Wang, 1999).  
The transition from a random protein chain to a protein with structure is referred to as folding. Proteins 
must be properly folded to exhibit the correct biological activity; this is their native state (N). Folding 
can be a complicated process so when an organism synthesizes a protein it requires the assistance of 
molecular chaperones to ensure the correct conformation. 
The alteration of the native structure, without change to the primary structure but with a loss of 
biological activity, is termed denaturation. Protein can be denatured by chemical, thermal or 
mechanical action. Chemical denaturants include urea and guanidine hydrochloride, which disrupt 
hydrophobic interactions and hydrogen bonds by preferentially binding to the protein to reduce the free 
energy and chemical potential of the denaturant. Protein structure can also be altered by extremes of 
pH, which cause increased repulsion between like charges. A protein will denature when heated, this 
occurs at a temperature specific to the primary structure. Shaking a protein solution can create foam 
films since proteins are able to stabilise the air water interface; a requirement of foam formation. In 
this location the protein structure can then be perturbed by hydrophobic and hydrophilic regions being 
pulled away from each other (Clarkson et al., 1999). The extent to which the structure is perturbed by 
denaturation can vary. A protein might loose its entire ordered structure and become completely 
unfolded, UC (Uversky, 2002). Alternatively, a protein may loose its tertiary structure but exhibit 
residual secondary structure and so become partially unfolded, UP (Uversky, 2002). If most of the 
native structure is retained but residue side chains become mobile this is referred to the molten globule 
state, MG (Pande and Rokhsar, 1998). Finally, the structure might only be altered slightly, N*, as with 
the allosteric effect. The allosteric effect occurs when a protein becomes ligand bound and under goes 
a conformation change in order to induce or inhibit biological activity (Allaby, 1998). 
Aggregation is the grouping and holding together of protein monomers by intermolecular interactions. 
There are various interactions between residues from adjoining monomers (Jones and Thorton, 1995), 
these include the formation of salt bridges between oppositely charged residues, the formation of 
sulphur bridges between cysteine residues and the formation of hydrogen bonds between residues. The 
latter is the most important and is referred to as intermolecular beta sheet. The aggregation process is 
driven by the thermodynamically unfavourable exposure of hydrophobic residues to water. By drawing 
upon various examples it becomes clear that the nature of aggregate structure depends upon the state of 
the protein monomer prior to aggregation. 
If the native protein structure is able to aggregate without structural change then an ordered aggregate 
will be formed as with insulin dimers and hexamers (Brangex et al., 1997) or virus protein capsids 
(Branden and Tooze, 1991), the aggregate size being limited by the regular nature of the structure. If 
the native protein structure is slightly altered by the allosteric effect again ordered aggregates can form 
as with the protein TLR4 (Saitoh et al., 2004).  
If the native protein structure is denatured to form a molten globule then upon aggregation a gel is 
formed and in this case the aggregate size is not limited by the nature of structure. The type of the gel 
formed depends upon the pH of the system (Gosal and Ross-Murphy, 2000, Clark et al., 2001), if the 
pH is close to the isoelectric point (pI) of the protein then a particulate gel will form or if the pH is 
well below the isoelectric point then a fibrilliar network gel will form. The isoeletric point of a protein 
is the pH at which the proteins net charge is zero and so repulsion between monomers is minimised. If 
the native protein structure becomes partially unfolded then a fibrilliar network gel is formed, with the 
initial aggregation being linear to form β-sheet fibrils followed by random physical cross-linking of the 
fibres (Clark et al., 2001).  
If the native protein structure is either denatured to a completely unfolded state or if it possesses high 
beta sheet content or if it has no structure then upon aggregation a fibril is formed and again the 
aggregate size is not limited. Fibril formation without denaturation is exemplified by certain peptides 
that have no structure in the native state (Zanuy et al., 2003) and also by prion proteins that have high 
beta sheet content (Prusiner, 1998). 
The work in this study focused on the protein ‘protective antigen’ (PA). This protein is being produced 
as the main constituent in a new and improved Anthrax vaccine to replace the existing vaccine (AVA), 
which is subject to flaws (Young and Collier, 2002) and safety concerns (Pittman et al., 2001). The US 
government is to spend $700 million on stockpiling the new vaccine in contracts with two companies, 
one of which is Avecia (Gillis, 2004). 
The PA is produced using genetically modified bacterial which were created by a DNA recombinant 
technique. Normally, PA is produced and released by Bacillus anthracis the bacterium that causes 
anthrax (Stubbs, 2002). PA is part of the anthrax toxin system. Its role is to bind to a cell surface, after 
which it self-associates to form a surface bound complex that can transport lethal factor (LF) and 
oedema factor (EF) into the cell. LF and EF cause cell damage by disrupting essential cell signalling 
which subsequently leads to death of the host. The rational behind a PA vaccine is to enhance the 
immune response against the PA and so render the anthrax toxin ineffective (Jendrek et al., 2003). 
The structure of PA has been determined by X-ray diffraction (Petosa et al., 1997). Various features of 
PA structure can be found on the Protein Data Bank (PDB) (Berman et al., 2000), which is available at 
http://www.pdb.org. The PDB identity code for PA is 1ACC. The images in Figure 3 and Figure 4 and 
the information in Table 1 has been acquired or derived from the PDB. The image of PA in Figure 3 
shows the arrangement of the non-hydrogen atoms, whilst its quality and usefulness are limited, it does 
give an idea of the shape and complexity of this molecule. The image of PA in Figure 4 is clearer and 
highlights α-helix and β-sheet elements of the secondary structure; α-helix represented by cylinders 
and β-sheet by arrows. 
 
 
Figure 3 Stick model of PA from PDB; carbon in white, oxygen in red, nitrogen in blue and sulphur in yellow 
 
 
Figure 4 Backbone and secondary structure arrangement of PA from PDB; α-helix represented by cylinders and β-sheet by 
arrows 
The percentages of secondary structural elements in PA are given in Table 1; structures assigned using 
STRIDE (Heinig and Frishman, 2004), an algorithm for determining secondary structure from the X-
ray structure based upon H-bonding pattern and backbone torsion angles. 
 
Table 1 Secondary structure of PA 
2° Structure Name Percentage /% 
α-helix 11.3 
Isolated beta bridge 3.0 
Extended beta strand 33.8 
310-helix 3.3 
pi-helix 0.00 
Turn 28.1 
Random coil 20.5 
 
PA is a large protein with a molecular weight of 82667 Daltons. The pH at which PA has zero net 
charge is theoretically 5.58; calculated from first principles assuming that all applicable species 
contribute to the charge. 
 
The PA protein is prone to aggregation which is a problem for processing and functionality. Therefore, 
the long term goal of the work is to examine the effect of environmental factors and additives that 
influence aggregation. The aim is to guide improvements in processing, formulation and storage of PA 
in order to reduce the degradation. The preliminary work which will be discussed here examines: 
• Thermal behaviour: using micro differential scanning calorimetry 
• Secondary structure changes: using infrared spectroscopy 
 
Methods and Materials 
The instruments used to examine PA structure and behaviour were a micro differential scanning 
calorimeter (DSC) and an infrared spectroscope (IR). 
A Setaram Micro DSC III was used to monitor thermal events. The instrument is capable of a 
temperature range of −20 to 120 °C, scanning rates between 0.001 to 1.2 °C min−1, a maximum sample 
volume of 850 µl and a resolution of 0.03 µW. Samples of 0.5 ml were used and de-ionised water was 
used as the reference. A scan rate of 0.5 °C min−1 was used. 
The IR spectroscope used was a Nicolet Avitar 360 FTIR spectroscope, capable of scanning from 400 
to 4000 cm−1 at a resolution of 1 to 32 cm−1. The instrument was used in transmission mode with 
calcium fluoride windows and a 6 µm Mylar spacer used to create a thin film of sample through which 
the IR radiation passes. A resolution of 4 cm−1 and a range of 1100 to 4000 cm−1 were used. 
The protein samples were provided by Avecia and contained phosphate buffered saline pH adjusted to 
7.4, they also contained Tween-20, a non-ionic surfactant, at less than 0.1 %v/v. The samples were 
stored at −18 °C and used as supplied. The concentration of PA in the sample used for micro DSC was 
1.9 g l−1, allowing the subtle thermal events to be monitored; a higher concentration might saturate the 
heat flow capability of the instrument. The concentration of PA in the sample used for IR was 18 g l−1 
to allow the protein contributions to be observed in the spectrum; the technique is limited to a 
concentration of at least 10 g l−1 when using H2O. 
The protein concentration was determined using ultraviolet (UV) absorbance at 280 nm in 8 M urea. 
An absorbance coefficient of 75845 M−1 cm−1 was determined from the primary structure of PA and 
the UV absorbance of model compounds in 8 M urea reported elsewhere (Pace et al., 1995). 
 
Results 
The 1.9 g l−1 PA sample was subjected to two heating and cooling cycles and results are given in 
Figure 5. An exothermic event was observed during the heating on the first cycle at around 47 °C, 
however, the same was not observed on the second cycle thus suggesting it is an irreversible thermal 
denaturation, an event for which similar results are reported elsewhere (Kudou et al., 2003). Initially, 
the sample appeared clear but once heat treated the sample appeared white suggesting the formation of 
a gel. The enthalpy change of the denaturation was 6 joules per gram of protein. The temperature and 
enthalpy of the transition during the heating on the first cycle were reproducible. The endothermic 
event at around 65 °C present during the cooling on both cycles is attributed to the behaviour of the gel 
and, as yet, has not been investigated further. 
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Figure 5 DSC trace of 1.9 g l−1 PA sample being heated and cooled at 0.5 °C min−1 
 
The 18 g l−1 PA sample was heated and cooled once in the IR. A spectrum was taken at various 
temperatures; the spectrum for 15 °C is shown in Figure 6. The heating rate cannot be quantified since 
the heating was stepwise; each spectrum taken once the new temperature had stabilised.  
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Figure 6 Full IR spectrum of 18 g l−1 PA sample at 15 °C, unsmoothed and smoothed 
 
The spectrum in Figure 6 is typical of water, which strongly absorbs IR radiation, and only a small 
contribution from the protein. This presents a challenge for examining protein in solution particularly 
since the important protein information is located around 1600 to 1700 cm−1 were there is a strong 
water absorption peak. The water contribution can be subtracted using a spectrum of sample without 
the protein present. This method is problematic since the water spectrum is affected by pH and 
temperature, which must be exactly matched between samples in order to accurately retrieve the 
protein contributions. In order to avoid these difficulties, the water contribution was subtracted using a 
new method devised by the author, which uses a gauss curve to model the contribution in the region 
important for protein structure, see Figure 7. 
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Figure 7 IR spectrum of 18 g l−1 PA sample at 15 °C with baseline and water band subtraction 
 
The gauss curve used to model the water band was fitted by adjusting its width, height and position so 
that it matched the recorded data in a region, 1700 to 1750 cm−1, where the protein does not absorb but 
where the water does. The subtraction revealed amide I band of the protein information which can be 
used to quantify secondary structure (Goormaghtigh et al., 1994, Barth and Zscherp, 2002). The amide 
bands arise from vibrations of bonds in the polypeptide backbone and coupling of these vibrations 
make them sensitive to the configuration of the backbone. Gauss curves were fitted to the amide I 
band, 1600 to 1700 cm−1, to determine secondary structure, see Figure 8; the position of a component 
curve relates the secondary structure type as shown by theory and experiment and the percentage area 
of the component curve directly relates to the quantity of the particular structure. The curves were 
fitted by locating their positions with fine structure enhancement (FSE) (Barth, 2000), the height and 
width of the curves was iteratively adjusted until the sum of all the curves matched the recorded 
spectrum.  
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Figure 8 Amide I band data and model with component curves for 18 g l−1 PA sample at 15 °C 
 
The quantities of secondary structures identified for the spectrum at 15 °C are 5.4 % α-helix and 37.8 
% β-sheet and 34.0 % turns; all structure assignments with percentages are given in Table 2. These IR 
results are comparable to the quantities determined by the X-ray data if it is assumed that the 
intermolecular β-sheet has been formed by random coil and if it is assumed that the 310-helix is 
contributing to the component curve for the turns. 
 
Table 2 Secondary structure of 18 g l−1 PA sample from IR spectrum at 15°C 
2° Structure Name Percentage /% 
Intermolecular β-Sheet 5.4 
β-Sheet 37.8 
Random Coil 17.4 
α-Helix 5.4 
Turn 34.0 
 
The quantity of secondary structure has also been determined using the spectra taken at higher 
temperatures during heating; these are represented graphically in Figure 9. The results for cooling are 
not shown. 
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Figure 9 Percentages of secondary structure of 18 g l−1 PA sample as a function of temperature 
 
It can be seen in Figure 9 that as the temperature increases there are alterations to secondary structure, 
most notably at around 48 °C where there is multiple shifts in the structure quantities and also notably 
for α-helix which increases in quantity at around 30 °C and is then completely lost around 46 °C. 
 
Discussion 
The change in appearance of the PA sample subsequent to heating indicates the formation of a gel, 
which is a large structure built up by aggregation. The infrared results show that aggregation was 
present even prior to heating as indicated by the presence of intermolecular β-sheet. Aggregation is a 
degradation event that can severely reduce product quality; reducing biological activity and altering 
immunogenicity (Wang, 1999). Investigating the prevention of aggregation is therefore an important 
requirement for the formulation of protein pharmaceuticals, a task to which IR is able to lend itself 
given that it is able to detect aggregation without interfering with the sample. 
The IR event at around 48 °C coincides with thermal denaturation observed with DSC. The secondary 
structure was not completely lost; there was however a substantial increase in random coil; a change 
that results from the break down of ordered secondary structures. Given that the correct structure is 
important for biological activity and that denaturation is the disruption of structure resulting in a loss 
of activity it would appear that the changes in secondary structure quantity around 48 °C are consistent 
with a denaturation event. It is important to observe structural changes that occur with degradation 
events in order to improve protein pharmaceutical stability. IR has demonstrated a capability that could 
be extended and used to investigate conditions for improving product stability. 
The gain and loss of α-helix content observed with increasing temperature coincides with the gain and 
loss of biological activity with increasing temperature as demonstrated elsewhere (Radha et al., 1996), 
the same work also reports that PA shows an increase α-helix content coinciding with the gain of 
biological activity. This suggests that the presence of the α-helix could be important for biological 
activity and therefore, might be important for the correct immunogenicity of PA in a vaccine. 
Understanding structural features required for activity is important for formulating effective protein 
pharmaceuticals, another application for which IR can be used. 
 
Conclusions 
The work has demonstrated that IR and DSC can be used to examine the degradation of protein 
products. The methods demonstrated and conditions surveyed have gone some way to meeting the 
stated aims of improving processing, formulation and storage. The work has exemplified the effect of 
temperature on the product and opened up opportunities for other environmental factors to be 
examined in relation to protein degradation and this will form the basis of future work. 
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